Navigation Links
RAPTOR in Medical News

Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.

LOS ANGELES, Nov. 2 /PRNewswire-FirstCall/ -- Vista Partners announced today that it has updated coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP). "We believe Raptor's operational approach will serve as the template for all small cap biotechnology companies as it promotes op...

Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.

LOS ANGELES, Oct. 9 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP). "Raptor's management team was pivotal in getting two drugs approved and creating stockholder value while at BioMarin Pharmaceutical, a $...

Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement

...A JOLLA, Calif., July 28 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... anticipated that the merged company will be named raptor Pharmaceuticals Corp. and be headquartered in Nova...unanimously approved by the boards of directors of raptor and TorreyPines, upon closing,...

Raptor Pharmaceuticals Corp. to Present at 2009 Cystinosis Research Network Family Conference

... NOVATO, Calif., July 16 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... stated goals and objectives. About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp. ("Raptor") is dedicated to...

Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier

... NOVATO, Calif., June 9 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ...n/prnh/20071022/NYM074LOGO ) Scientists at raptor and Roche will actively collaborate on the project. raptor will receive an initial upfront fee for the collab...

Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000

... Winery, Lange Estate, Maysara Winery, Patricia Green Cellars, Patton Valley Vineyards, Penner-Ash Wine Cellars, Ponzi Vineyards, R. Stuart & Co., raptor Ridge Winery, Rex Hill Vineyards, Scott Paul Wines, Shea Wine Cellars, Silvan Ridge, Solena Cellars, Soter Vineyards, St. Innocent Winery, Stoller Vin...

Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences

...tp://www.rodmanandrenshaw.com/conferences About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp. ("Raptor") is a publicly tra...rug targeting platforms and formulation expertise. raptor focuses on underserved patient populations where i...

Wiley X Eyewear(R) Announces Successful Resolution of Patent Infringement Litigation Against PanOptx(R), Inc.

... permeable shield that provides eye protection while preventing fogging. This affects sales of PanOptx's Velocity CV series of frames -- including the raptor CV, Sirocco CV, Diablo CV, Kona CV, Gust CV, Convertible CV, Solano CV, Bora CV, Churada CV, Whirlwind CV and Chubasco CV -- as well as the Warrior pr...
RAPTOR in Medical Technology

Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications

...VATO, Calif., April 29 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ...ing with their therapeutic functions. About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp. ("Raptor") is dedicated to s...

Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

...NOVATO, Calif., April 13 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... and file an NDA in 2010. In February, 2009, raptor announced the completion of patient enrollment in ...expected later this year. In November, 2008, raptor entered into an agreement with the Centre Hospital...

Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)

... NOVATO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ...er indications. Under a license with UC San Diego, raptor is developing cysteamine and a delayed-release for...eatment option for their disease. UC San Diego and raptor understand the need to deliver a treatment solutio...

Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program

...l proportion of them are recurring drinkers of alcoholic beverages. About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp. ("Raptor") is dedicated to speeding the delivery of n...

Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease

...ing frequency and gastrointestinal side effects. raptor obtained an exclusive, worldwide license from the ...IIa clinical study of cysteamine in NASH patients. raptor plans to initiate a pivotal study of DR Cysteamine in cystinosis patients in 2009. About raptor Pharmaceuticals Corp. ...

Raptor Pharmaceuticals Provides Update on Targeting Platforms

... NOVATO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ...dy of RAP and its interactions, and researchers at raptor will test RAP sequence variants designed to withst...our growing in-house set of targeting peptides." raptor also announced that the Patent Office of Japan wil...

Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)

...eviously announced collaboration agreement between raptor and UCSD to evaluate the safety and potential effi...y at UCSD's General Clinical Research Center while raptor is providing funding and clinical supplies of cyst...s"), a rare and genetic lysosomal storage disease. raptor is developing cysteamine and a delayed release for...

Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease

... raptor to Support Phase 2a Clinical Trial at UCSD NOVAT...University's General Clinical Research Center, and raptor will provide funding and clinical supply of Cysteamine. In March 2008, raptor acquired an exclusive, worldwide license to certai...

Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)

...ts of the study are expected in June 2008. About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp.'s business consists of two s...age development company Bennu Pharmaceuticals Inc. raptor Inc. bioengineers novel drug candidates and drug-t...

Raptor Pharmaceuticals Provides Update of Product Programs

...inical studies of its RAP liver targeting program, raptor has initiated a pre-IND program for HepTide(TM) (i...c. stated, "We are very excited to be working with raptor as it advances toward clinical trials." Dr. Chris...te http://www.regprofessional.com . In addition, raptor has initiated proof-of-principle preclinical studi...
RAPTOR in Biological News

Newly discovered birdlike dinosaur is oldest raptor ever found in South America

Relative of Velociraptor rewrites evolutionary charts The recent discovery of a 90-million-year-old dinosaur in Patagonia demonstrates that dromaeosaurs, a group of carnivorous theropods that includes Velociraptor and is closely related to birds, originated much earlier than previously thought. ...

Tiny pest-eating insect fights fruit flies

... of other types of pests. The study investigated the use of Muscidifurax raptor to control fruit flies in vineyards. Until recently, fruit flies were usual...demands from vineyard owners. Kopongo noted that using the Muscidifurax raptor parasitoid to control flies benefits the environment and promotes agricultu...

Ecologists discover city is 'uber-forest' for big owls

...gan in 2001 and has been sponsored by the Carolina raptor Center, has been large-scale and in-depth, with re...weve found because someone either called in to the raptor Center and reported young on the ground or were wa...he surface. For example, the coopers hawk, another raptor known to be common in cities like Charlotte, has b...

DNA from feathers tells tale of eagle fidelity

... monogamous, and this study provides the first genetic confirmation of monogamy in at least one species, DeWoody said. "It's very likely that other raptor biologists will follow this with similar studies on other species of interest like bald eagles," he said. This project is one part of a larger rese...
RAPTOR in Biological Technology

Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)

LOS ANGELES, July 31 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Raptor Pharmaceuticals Corp. "Raptor's drug candidates, which target billion dollar markets, are progressing through the clinic at a rapid pace. The Company will present Phase 2 results for Conv...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

...reement and Plan of Merger by and between TPTX and raptor Pharmaceuticals Corp., TPTX's Board approved cance...s with the SEC. Investors and security holders of raptor and TorreyPines are urged to read the joint proxy ...ecause it will contain important information about raptor and TorreyPines. Raptor's and TorreyPines' stockho...

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference

...ls (Nasdaq: NABI ), OXiGENE Inc. (Nasdaq: OXGN ), Access Pharmaceuticals (OTC Bulletin Board: ACCP), Echo Therapeutics (OTC Bulletin Board: ECTE), raptor Pharmaceuticals (OTC Bulletin Board: RPTP), Neoprobe Corp. (OTC Bulletin Board: NEOP) and Oxygen Biotherapeutics (OTC Bulletin Board: OXBO). Jesu...

Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis

... NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... study are expected in the third quarter of 2009. raptor plans to follow the Phase 2b clinical study with a...loped by Raptor. We're pleased to collaborate with raptor in this effort to advance the standard of care in ...

Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board

... and Ph.D. in bioorganic chemistry from Harvard University in 1991. About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp. ("Raptor") is a development-stage biopharmaceutical c...

Raptor Pharmaceuticals Closes $10 Million Private Placement

...nd more effective therapeutics to market." About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp. ("Raptor") consists of a pre...osis and non-alcoholic steatohepatitis ("NASH"). raptor preclinical programs target cancer, neurodegenerat...

Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008

...ted by the Cystinosis Research Foundation ("CRF"), raptor is developing a delayed-release version of cysteam... on safety and efficacy studies performed at UCSD, raptor believes that Cystinosis patients could benefit fr... of the Cystinosis patients and their families." raptor plans to initiate an expanded study of its final p...

Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention

... NOVATO, Calif., June 12 /PRNewswire/ -- raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), ...t please visit: http://www.bio2008.org . About raptor Pharmaceuticals Corp. raptor Pharmaceuticals Corp.'s business consists of two s...

Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease

... NOVATO, Calif., June 9 /PRNewswire-FirstCall/ -- raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ...drug designation for cysteamine in HD. Our team at raptor is well-versed in developing and gaining regulator...patitis ("NASH") and Huntington's disease. About raptor Pharmaceuticals Corp. ...

SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility

...rida's premier basketball training facility for NBA stars and young emerging basketball talent. Dee Brown, former Boston Celtic, Orlando Magic Toronto raptor player, winner of the "no look" 1991 Slum Dunk Contest and WNBA Head Coach, is the CEO and head instructor at The Edge Training Facility. At the Edge ...
Other Tags
(Date:7/11/2014)... (PRWEB) July 11, 2014 Utilizing the ... own, Dr. William Koenig, has topped a record number ... he has performed over 400 successful procedures without the ... Koenig is well known across the country for his ... safety record has long been the foundation for numerous ...
(Date:7/11/2014)... 2014 (HealthDay News) -- Children who have emergency ... complications and potentially even death than those who ... However, the Johns Hopkins researchers noted that ... researchers analyzed data on nearly 440,000 simple emergency ... over a 22-year period. The surgeries are ...
(Date:7/11/2014)... The report “Probiotics Market by Products (Functional Foods, ... Therapeutic, Preventive Health Care) & Ingredients (Lactobacilli, Bifidobacteria, ... ” defines and segments the global probiotics market ... value of probiotic products and ingredients. The report ... the global market with an analysis of trends, ...
(Date:7/11/2014)... 2014 Global enterprises today are shifting ... day-to-day management activities. Managed services offer these global enterprises ... economic slowdown resulted into rising operational costs to companies. ... considered to be the global market driver for expanding ... global managed services market is estimated to grow from ...
(Date:7/11/2014)... Toledo, Ohio (PRWEB) July 11, 2014 ... (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number ... in blood sugar, abdominal issues and even death from ... exposed. , According to the Times report , ... events in 2013 reported by patients was almost 14% ...
Breaking Medicine News(10 mins):Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3
(Date:7/11/2014)... . X-ray ... of X-rays through a specimen instead of attenuation resulting ... often of much higher quality than those based on ... Pfeiffer are particularly interested in developing new approaches for ... imaging. One main goal is to make this method ...
(Date:7/11/2014)... 2014, Shenzhen, China Researchers from Salk Institute for ... first time evaluated the safety and reliability of ... developed a new method, TALEN-HDAdV, which could significantly ... cell (hiPSC). This study published online in ... foundation for stem cell-based gene therapy. , The ...
(Date:7/11/2014)... 11, 2014 Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
Other Contents